Qiao Zhang

Qiao Zhang

Auto-generated profile, based on publicly available information

Qiao Zhang

L'Oréal Research and Innovation Shanghai China

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 June 2024 in Cancer Research
Verified
Journal Article
Open access
PDF file
LLLingling Li
Lingling Li
DJDongxian Jiang
Dongxian Jiang
HLHui Liu
Hui Liu
CGChunmei Guo
Chunmei Guo
QZQiao Zhang
Qiao Zhang
CDChen Ding
Chen Ding
Colorectal cancer is the second most common malignant tumor worldwide. Analysis of the changes that occur during colorectal cancer progression could provide insights into the molecular mechanisms driving colorectal cancer development and identify improved treatment strategies. In this study, we performed an integrated multiomic analysis of 435 trace tumor samples from 148 patients with colorectal cancer, covering nontumor, intraepithelial neoplasia (IEN), infiltration, and advanced stage colorectal cancer phases. Proteogenomic analyses demonstrated that KRAS and BRAF mutations were mutually exclusive and elevated oxidative phosphorylation in the IEN phase. Chr17q loss and chr20q gain were also mutually exclusive, which occurred predominantly in the IEN and infiltration phases, respectively, and impacted the cell cycle. Mutations in TP53 were frequent in the advanced stage colorectal cancer phase and associated with the tumor microenvironment, including increased extracellular matrix rigidity and stromal infiltration. Analysis of the profiles of colorectal cancer based on consensus molecular subtype and colorectal cancer intrinsic subtype classifications revealed the progression paths of each subtype and indicated that microsatellite instability was associated with specific subtype classifications. Additional comparison of molecular characteristics of colorectal cancer based on location showed that ANKRD22 amplification by chr10q23.31 gain enhanced glycolysis in the right-sided colorectal cancer. The AOM/DSS-induced colorectal cancer carcinogenesis mouse model indicated that DDX5 deletion due to chr17q loss promoted colorectal cancer development, consistent with the findings from the patient samples. Collectively, this study provides an informative resource for understanding the driving events of different stages of colorectal cancer and identifying the potential therapeutic targets. Significance: Characterization of the proteogenomic landscape of colorectal cancer during progression provides a multiomic map detailing the alterations in each stage of carcinogenesis and suggesting potential diagnostic and therapeutic approaches for patients.

14 September 2023 in Journal of Functional Foods
Verified
Journal Article
Open access
QZQiao Zhang
Qiao Zhang
XTXiaoxian Tang
Xiaoxian Tang
XZXueying Zhang
Xueying Zhang
YHYuanchang He
Yuanchang He
YLYongcheng Li
Yongcheng Li

12 December 2025 in Journal of Cosmetic Dermatology
Verified
Journal Article
Open access
CHChunyan HE
Chunyan HE
RWRanran Wang
Ranran Wang
QZQiao Zhang
Qiao Zhang
YWYehong Wang
Yehong Wang
NHNan Huang
Nan Huang
Background: Recombinant human collagen peptides (rhCol peptides) have demonstrated considerable promise in various biomedical applications, including wound healing, dermatological treatments, aesthetic procedures, cosmetic formulations, and personal healthcare. Recently, their incorporation as a bioactive component in dermal filler products has gained significant attraction within the aesthetic and cosmetic fields. Aims: To elucidate the beneficial bio‐efficacy of rhCol peptides as a dermal filler, underlying mechanisms from both the cell and tissue levels were explored. Methods: The stimulatory effect of rhCol peptides on extracellular matrix (ECM) production was confirmed in 2D human fibroblast cultures at mRNA levels. Subsequently, its impact on skin rejuvenation was illustrated, utilizing a novel, in‐house developed 3D in vitro filler biomimetic skin model, tissue morphology, epidermal proliferation and differentiation, as well as dermal ECM deposition were investigated. Transcriptomic analysis further offered an in‐depth view of molecular pathways underlying the phenotypical change observed at cellular and tissue levels. Results: In the 2D cell model, matrix remodeling–related genes such as Collagen type I and III, Elastin, Fibrillin 1, Hyaluronic acid synthases 1, 2, and 3 were significantly upregulated upon treatment with rhCol III peptides. Its direct binding to the dermal scaffold was confirmed within a novel filler biomimetic in vitro skin model, providing compelling evidence of their beneficial effects on both epidermal and dermal compartments, embodied in improved epidermis regeneration (Ki67, COL17A1) and dermis remodeling (FBN1 and glycosaminoglycans). Furthermore, transcriptomic analysis provided valuable insights into the potential mechanisms of downregulated inflammation, senescence and apoptosis; upregulated integrin binding; and extracellular matrix formation resulted from the binding of rhCol III peptides to the dermal scaffold. Conclusions: These findings collectively support the pro‐ECM potential of such rhCol III peptides as a promising biomaterial for dermal filler, as well as potential cosmetic applications. Limited by the gap between in vitro mimetic model and real injection, further clinical trials should be taken to reconfirm the potential benefits.

17 June 2026
Verified
Other
Open access
PDF file
LLLingling Li
Lingling Li
DJDongxian Jiang
Dongxian Jiang
HLHui Liu
Hui Liu
CGChunmei Guo
Chunmei Guo
QZQiao Zhang
Qiao Zhang
CDChen Ding
Chen Ding
Supplementary Figure 10 and related legend of the revised manuscript.

17 June 2026
Verified
Other
Open access
PDF file
LLLingling Li
Lingling Li
DJDongxian Jiang
Dongxian Jiang
HLHui Liu
Hui Liu
CGChunmei Guo
Chunmei Guo
QZQiao Zhang
Qiao Zhang
CDChen Ding
Chen Ding
Supplementary Figure 7 and related legend of the revised manuscript.

17 June 2026
Verified
Other
Open access
PDF file
LLLingling Li
Lingling Li
DJDongxian Jiang
Dongxian Jiang
HLHui Liu
Hui Liu
CGChunmei Guo
Chunmei Guo
QZQiao Zhang
Qiao Zhang
CDChen Ding
Chen Ding
Supplementary Figure 2 and related legend of the revised manuscript.